H19 and pulmonary arterial hypertension: Furthermore, GapmeR-mediated downregulation of H19 in PAB- and MCT-induced PH rat models improved PAH features, including RV hypertrophy, capillary rarefaction, and fibrosis without influencing pulmonary vascular remodeling [31].